EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Aberrant coupling of glutamate and tyrosine kinase receptors enables neuronal control of brain-tumor growth

Corina Anastasaki, Rui Mu, Chloe M Kernan, Xuanwei Li, Rasha Barakat, Joshua P Koleske, Yunqing Gao, Olivia M Cobb, Xinguo Lu, Charles G Eberhart, Joanna J Phillips, Jennifer M Strahle und 4 weitere

Neuron · 2025

DOI: 10.1016/j.neuron.2025.08.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuron, 2025. Verfasst von Corina Anastasaki und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA. Hauptthemen laut MEDLINE: Brain Neoplasms, Neurons, Astrocytoma, Receptors, Glutamate. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIMH NIH HHS, NINDS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Direct and paracrine neuron-cancer interactions govern tumor development and progression. While neuron-elaborated neurotransmitters, like glutamate, support neoplastic growth, the mechanism underlying tumor intracellular mitogenic signaling and proliferation remains an unresolved question in cancer neuroscience. Herein, we discover that glutamate receptor (GluR) stimulation phosphorylates sarcoma proto-oncogene (Src) to activate platelet-derived growth factor (PDGF) receptor-α (PDGFRα)-dependent extracellular-regulated kinase (ERK) signaling and drive glioma growth. Using single-cell transcriptomic datasets and unique laboratory-generated humanized models of the most common brain tumor in children (pilocytic astrocytoma [PA]), we identify glutamatergic pathway enrichment in tumor cells, where glutamate increases PA proliferation without changing membrane depolarization. Aberrant GRID2 and GRIK3 GluR expression increases rat sarcoma (RAS)/ERK signaling by selective Src-mediated PDGFRα activation. Moreover, genetic or pharmacologic GRID2/GRIK3 and PDGFRA inhibition reduce PDGFRα/RAS/ERK activation, PA cell proliferation, and PA xenograft growth. Taken together, these observations establish a conceptual framework for understanding similar neurotransmitter dependencies in other cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsNeuronsAstrocytomaReceptors, GlutamateAnimalsHumansProto-Oncogene MasMiceCell ProliferationReceptor, Platelet-Derived Growth Factor alphaRatsGlutamic AcidCell Line, TumorKainic Acid ReceptorsSignal Transductionsrc-Family Kinases

Stichwörter der Autor:innen

ERK signalingcancer neuroscienceglutamate receptorpediatric brain tumorreceptor tyrosine kinase

Substanzen

Proto-Oncogene MasReceptors, GlutamateReceptor, Platelet-Derived Growth Factor alphaGlutamic AcidKainic Acid Receptorssrc-Family KinasesMAS1 protein, human

Autor:innen und Institutionen

  • Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
  • Department of Neurosurgery, Washington University School of Medicine, St. Louis, MO, USA.
  • Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
  • Department of Neuropathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Department of Neurological Surgery, Brain Tumor Center, University of California, San Francisco, San Francisco, CA, USA.
  • Department of Pathology, Immunology, and Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.

Förderung

  • NIMH NIH HHS
  • NINDS NIH HHS
  • NCI NIH HHS
  • National Institutes of Health
  • Washington University Taylor Family Institute for Innovative Psychiatric Research
  • National Institutes of Health National Cancer Institute
  • National Institute of Neurological Disorders and Stroke
  • Pediatric Brain Tumor Foundation

Zitieren

APA

Anastasaki, C., Mu, R., Kernan, C. M., Li, X., Barakat, R., Koleske, J. P., Gao, Y., Cobb, O. M., Lu, X., Eberhart, C. G., Phillips, J. J., Strahle, J. M., Dahiya, S., Mennerick, S. J., Rodriguez, F. J., & Gutmann, D. H. (2025). Aberrant coupling of glutamate and tyrosine kinase receptors enables neuronal control of brain-tumor growth. Neuron. https://doi.org/10.1016/j.neuron.2025.08.005

Vancouver

Anastasaki C, Mu R, Kernan CM, Li X, Barakat R, Koleske JP, et al. Aberrant coupling of glutamate and tyrosine kinase receptors enables neuronal control of brain-tumor growth. Neuron. 2025. doi:10.1016/j.neuron.2025.08.005

BibTeX
@article{Anastasaki2025,
  author = {Anastasaki, Corina and Mu, Rui and Kernan, Chloe M and Li, Xuanwei and Barakat, Rasha and Koleske, Joshua P and Gao, Yunqing and Cobb, Olivia M and Lu, Xinguo and Eberhart, Charles G and Phillips, Joanna J and Strahle, Jennifer M and Dahiya, Sonika and Mennerick, Steven J and Rodriguez, Fausto J and Gutmann, David H},
  title = {Aberrant coupling of glutamate and tyrosine kinase receptors enables neuronal control of brain-tumor growth},
  journal = {Neuron},
  year = {2025},
  doi = {10.1016/j.neuron.2025.08.005}
}
Kostenlos starten →